GlassScriptPhysician profile
Andrew I Kim
NPI 1790968816
$8,316.06
in general payments reported to CMS, 2019-2025
42 companies · $1,275 in 2025
The $1,275 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,000 · 2020: $1,103 · 2021: $1,303 · 2022: $1,400 · 2023: $773 · 2024: $1,462 · 2025: $1,275.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,510.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,510.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $4,025.08 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $431.35 | 2019-2025 | Entyvio, Eohilia, Gattex |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $353.40 | 2019-2025 | Xifaxan, Relistor, Trulance |
| Gilead Sciences, INC. | $339.91 | 2019-2025 | |
| Stimwave Technologies Incorporated | $319.32 | 2019-2022 | |
| Janssen Biotech, INC. | $295.37 | 2019-2024 | Stelara, Tremfya, Simponi Aria |
| Nestle Healthcare Nutrition INC. | $271.80 | 2020-2023 | |
| Ironwood Pharmaceuticals, INC | $241.33 | 2019-2023 | Linzess |
| Aimmune Therapeutics, INC. | $199.17 | 2024-2025 | Zenpep |
| Braintree Laboratories, INC. | $164.68 | 2019-2024 | Suflave, Sutab |
| Redhill Biopharma INC. | $145.10 | 2020-2022 | |
| Genzyme Corporation | $131.34 | 2023-2025 | |
| E.R. Squibb & Sons, L.L.C. | $124.52 | 2021 | |
| Endogastric Solutions, INC | $114.07 | 2019 | |
| Qol Medical, LLC | $113.92 | 2019-2021 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.